Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 352

GV pushes Envelop VR to $5.5m

Virtual reality software developer Envelop VR has completed a series A round that featured a $1.5m investment by corporate venturing unit GV.

Jan 19, 2016

MindTouch reaches out to SAP in $12m round

SAP was among the participants as customer engagement technology developer MindTouch raised $12m in series A capital, 11 years after it was founded.

Jan 19, 2016

Tmunity sells Eli Lilly on $10m series A

The pharmaceutical firm's Lilly Asia Ventures unit is co-investing in the T-cell technology developer with University of Pennsylvania.

Jan 19, 2016

Neura recognises corporates for $11m series A

The SingTel-backed internet-of-things intelligence technology developer secured the funding in a round featuring Lenovo and AXA.

Jan 19, 2016

PierianDx sequences $9.25m series A

The DNA sequencing technology developer raises $9.25m from Utah University's Arup Laboratories and others to further develop its product and increase sales and marketing.

Jan 19, 2016

Jerry Education studies for $40m series A

A fund co-created by Shanghai Jiao Ton University's investment unit backs Jerry Education's $40m round to open more schools and develop an online platform.

Jan 19, 2016

Intel helps relay $15m to Savioke

Intel Capital has led a series A round for the robot developer, which previously obtained seed funding from backers including Alphabet.

Jan 19, 2016

Salesforce hunts down FinanceFox for $5.5m round

FinanceFox reportedly built its mobile insurance management platform on the Salesforce platform, and has now raised cash in a round led by Salesforce Ventures.

Jan 18, 2016

Tmunity sells Eli Lilly on $10m series A

The pharmaceutical firm's Lilly Asia Ventures unit is co-investing in the T-cell technology developer with University of Pennsylvania.

Jan 18, 2016

Lodo loads up series A with $17m

Lodo Therapeutics has been launched by investment firm Accelerator Corporation with series A capital from investors including AbbVie, Eli Lilly, Wuxi PharmaTech, Pfizer, IBM and Johnson & Johnson.

Jan 18, 2016
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here